BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34449687)

  • 1.
    Kantipudi S; Harder D; Bonetti S; Fotiadis D; Jeckelmann JM
    Methods Protoc; 2021 Jul; 4(3):. PubMed ID: 34449687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Heavy Chain 4F2hc Modulates the Substrate Affinity and Specificity of the Light Chains LAT1 and LAT2.
    Kantipudi S; Jeckelmann JM; Ucurum Z; Bosshart PD; Fotiadis D
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33066406
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sub-Nanometer Cryo-EM Density Map of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
    Jeckelmann JM; Fotiadis D
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32993041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of substrates and inhibitors of the human heterodimeric transporter 4F2hc-LAT1 using purified protein and the scintillation proximity radioligand binding assay.
    Kantipudi S; Harder D; Fotiadis D
    Front Physiol; 2023; 14():1148055. PubMed ID: 36895635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Volta Phase Plate Cryo-EM Structure of the Human Heterodimeric Amino Acid Transporter 4F2hc-LAT2.
    Jeckelmann JM; Fotiadis D
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30795505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Yeast Cell-Based Transport Assay for the Functional Characterization of Human 4F2hc-LAT1 and -LAT2, and LAT1 and LAT2 Substrates and Inhibitors.
    Kantipudi S; Fotiadis D
    Front Mol Biosci; 2021; 8():676854. PubMed ID: 34124158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of the human LAT1-4F2hc heteromeric amino acid transporter complex.
    Yan R; Zhao X; Lei J; Zhou Q
    Nature; 2019 Apr; 568(7750):127-130. PubMed ID: 30867591
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human LAT1-4F2hc (SLC7A5-SLC3A2) transporter complex: Physiological and pathophysiological implications.
    Kahlhofer J; Teis D
    Basic Clin Pharmacol Toxicol; 2023 Nov; 133(5):459-472. PubMed ID: 36460306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of human heteromeric amino acid transporters in the yeast Pichia pastoris.
    Costa M; Rosell A; Álvarez-Marimon E; Zorzano A; Fotiadis D; Palacín M
    Protein Expr Purif; 2013 Jan; 87(1):35-40. PubMed ID: 23085088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detergent-induced stabilization and improved 3D map of the human heteromeric amino acid transporter 4F2hc-LAT2.
    Meury M; Costa M; Harder D; Stauffer M; Jeckelmann JM; Brühlmann B; Rosell A; Ilgü H; Kovar K; Palacín M; Fotiadis D
    PLoS One; 2014; 9(10):e109882. PubMed ID: 25299125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of substrate transport and inhibition of the human LAT1-4F2hc amino acid transporter.
    Yan R; Li Y; Müller J; Zhang Y; Singer S; Xia L; Zhong X; Gertsch J; Altmann KH; Zhou Q
    Cell Discov; 2021 Mar; 7(1):16. PubMed ID: 33758168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contribution of LAT1-4F2hc in Urological Cancers via Toll-like Receptor and Other Vital Pathways.
    Zhao X; Sakamoto S; Maimaiti M; Anzai N; Ichikawa T
    Cancers (Basel); 2022 Jan; 14(1):. PubMed ID: 35008399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural bases for the interaction and stabilization of the human amino acid transporter LAT2 with its ancillary protein 4F2hc.
    Rosell A; Meury M; Álvarez-Marimon E; Costa M; Pérez-Cano L; Zorzano A; Fernández-Recio J; Palacín M; Fotiadis D
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):2966-71. PubMed ID: 24516142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function and structure of heterodimeric amino acid transporters.
    Wagner CA; Lang F; Bröer S
    Am J Physiol Cell Physiol; 2001 Oct; 281(4):C1077-93. PubMed ID: 11546643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterodimeric amino acid transporters: molecular biology and pathological and pharmacological relevance.
    Kanai Y; Endou H
    Curr Drug Metab; 2001 Dec; 2(4):339-54. PubMed ID: 11766986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of 4F2hc with light chains LAT1, LAT2 or y+LAT2 requires different domains.
    Bröer A; Friedrich B; Wagner CA; Fillon S; Ganapathy V; Lang F; Bröer S
    Biochem J; 2001 May; 355(Pt 3):725-31. PubMed ID: 11311135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complete assembly of human LAT1-4F2hc complex provides insights into its regulation, function and localisation.
    Wu D; Yan R; Song S; Swansiger AK; Li Y; Prell JS; Zhou Q; Robinson CV
    Nat Commun; 2024 May; 15(1):3711. PubMed ID: 38697966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SLC3 and SLC7 families of amino acid transporters.
    Fotiadis D; Kanai Y; Palacín M
    Mol Aspects Med; 2013; 34(2-3):139-58. PubMed ID: 23506863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The 4F2hc/LAT1 complex transports L-DOPA across the blood-brain barrier.
    Kageyama T; Nakamura M; Matsuo A; Yamasaki Y; Takakura Y; Hashida M; Kanai Y; Naito M; Tsuruo T; Minato N; Shimohama S
    Brain Res; 2000 Oct; 879(1-2):115-21. PubMed ID: 11011012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-type amino acid transporter-1 expressed in human astrocytomas, U343MGa.
    Asano S; Kameyama M; Oura A; Morisato A; Sakai H; Tabuchi Y; Chairoungdua A; Endou H; Kanai Y
    Biol Pharm Bull; 2007 Mar; 30(3):415-22. PubMed ID: 17329830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.